Title: 2017 ACVIM Forum Research Abstract Program Document date: 2017_6_15
ID: ri2w5iby_627
Snippet: All three potassium supplements were effective in treating hypokalemia secondary to CKD in the majority of cats despite quite variable dosing, but treatment response depending on the definition of response used. No indication of alkalinizing effect was seen, and prospective studies are needed for more thorough assessment. Symmetric dimethylarginine (SDMA) and neutrophil gelatinaseassociated lipocalin (NGAL) have been suggested as useful biomarker.....
Document: All three potassium supplements were effective in treating hypokalemia secondary to CKD in the majority of cats despite quite variable dosing, but treatment response depending on the definition of response used. No indication of alkalinizing effect was seen, and prospective studies are needed for more thorough assessment. Symmetric dimethylarginine (SDMA) and neutrophil gelatinaseassociated lipocalin (NGAL) have been suggested as useful biomarkers for evaluating renal disease. The objective of this study was to assess the circulating SDMA and NGAL concentrations in dogs before and after correction of dehydration.
Search related documents:
Co phrase search for related documents- prospective study and SDMA symmetric dimethylarginine: 1, 2
- renal disease and SDMA symmetric dimethylarginine: 1, 2, 3
- renal disease and study objective: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
- renal disease and symmetric dimethylarginine: 1, 2, 3
- renal disease and thorough assessment: 1
- renal disease and treatment response: 1, 2, 3, 4, 5, 6, 7
- renal disease and useful biomarker: 1
- renal disease evaluate and study objective: 1
- response definition and treatment response: 1
- response definition and useful biomarker: 1
- SDMA symmetric dimethylarginine and symmetric dimethylarginine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- SDMA symmetric dimethylarginine and treatment response: 1
- study objective and symmetric dimethylarginine: 1, 2
- study objective and thorough assessment: 1
- study objective and treatment response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40
- study objective and useful biomarker: 1, 2
- study objective and variable dosing: 1
- symmetric dimethylarginine and treatment response: 1
- treatment response and useful biomarker: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date